Form PRE 14C - Other preliminary information statements
SEC Accession No. 0001104659-22-120384
Filing Date
2022-11-18
Accepted
2022-11-18 17:13:43
Documents
1
Period of Report
2022-11-18

Document Format Files

Seq Description Document Type Size
1 PRE 14C tm2231000d1_pre14c.htm PRE 14C 56611
  Complete submission text file 0001104659-22-120384.txt   57722
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

EIN.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: PRE 14C | Act: 34 | File No.: 000-55535 | Film No.: 221402792
SIC: 2834 Pharmaceutical Preparations